Posted by Two Blokes
Candel Therapeutics Inc (NASDAQ:CADL) said on Wednesday the US Food and Drug Administration has granted Regene
Source: Two Blokes Trading
Posted by Two Blokes
I'm buying the dip in IHS, targeting $8 by Q3 2025, driven by improving free cash flow and a compelling valuat
Source: Two Blokes Trading
Posted by Two Blokes
Sono-Tek Corporation (SOTK) came out with quarterly earnings of $0.02 per share, beating the Zacks Consensus E
Source: Two Blokes Trading
Posted by Two Blokes
Phreesia (PHR) came out with a quarterly loss of $0.07 per share versus the Zacks Consensus Estimate of a loss
Source: Two Blokes Trading
Posted by Two Blokes
Reservoir Media, Inc. (RSVR) came out with quarterly earnings of $0.04 per share, in line with the Zacks Conse
Source: Two Blokes Trading
Posted by Two Blokes
Japan approves ILMN's TSO Comprehensive, marking a key step forward in global precision oncology adoption and
Source: Two Blokes Trading
Posted by Two Blokes
iHeartMedia's Q1 2025 revenues grew 1% to $807.1 million, outperforming peers amid industry-wide broadcast ad
Source: Two Blokes Trading
Posted by Two Blokes
WAYNE, Pa., May 28, 2025 (GLOBE NEWSWIRE) -- Aclaris Therapeutics, Inc. (NASDAQ: ACRS), a clinical-stage bioph
Source: Two Blokes Trading
Posted by Two Blokes
CHERRY HILL, N.J., May 28, 2025 (GLOBE NEWSWIRE) -- Today, Corcentric, a leading global provider of best-in-cl
Source: Two Blokes Trading
Posted by Two Blokes
The stock market remains optimistic this morning after President Trump postponed new tariffs on EU imports.
Source: Two Blokes Trading
Posted by Two Blokes
Robust customer & shareholder-friendly initiatives boost DAL's prospects. However, high operating costs are a
Source: Two Blokes Trading
Posted by Two Blokes
BNS' second-quarter fiscal 2025 earnings decline 1.6% due to higher provisions and expenses offsetting revenue
Source: Two Blokes Trading